- Home
- COLL vs UP Comparison
COLL vs UP Comparison
Compare COLL & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- UP
- Stock Information
- Founded
- COLL 2002
- UP 2013
- Country
- COLL United States
- UP United States
- Employees
- COLL N/A
- UP N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- UP Aerospace
- Sector
- COLL Health Care
- UP Consumer Discretionary
- Exchange
- COLL Nasdaq
- UP Nasdaq
- Market Cap
- COLL 958.8M
- UP 1.0B
- IPO Year
- COLL 2015
- UP N/A
- Fundamental
- Price
- COLL $36.04
- UP $2.43
- Analyst Decision
- COLL Strong Buy
- UP
- Analyst Count
- COLL 4
- UP 0
- Target Price
- COLL $44.25
- UP N/A
- AVG Volume (30 Days)
- COLL 463.5K
- UP 11.7M
- Earning Date
- COLL 11-06-2025
- UP 11-06-2025
- Dividend Yield
- COLL N/A
- UP N/A
- EPS Growth
- COLL N/A
- UP N/A
- EPS
- COLL 1.06
- UP N/A
- Revenue
- COLL $707,007,000.00
- UP $765,885,000.00
- Revenue This Year
- COLL $22.23
- UP $174.46
- Revenue Next Year
- COLL $2.78
- UP N/A
- P/E Ratio
- COLL $34.38
- UP N/A
- Revenue Growth
- COLL 22.61
- UP N/A
- 52 Week Low
- COLL $23.23
- UP $0.74
- 52 Week High
- COLL $42.29
- UP $3.50
- Technical
- Relative Strength Index (RSI)
- COLL 45.96
- UP 57.58
- Support Level
- COLL $34.71
- UP $1.97
- Resistance Level
- COLL $36.57
- UP $2.37
- Average True Range (ATR)
- COLL 1.25
- UP 0.34
- MACD
- COLL -0.59
- UP -0.05
- Stochastic Oscillator
- COLL 25.25
- UP 38.08
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.